Viewing Study NCT00586612

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:16 PM
Ignite Modification Date: 2026-07-19 @ 2:11 AM
Study NCT ID: NCT00586612
Status: COMPLETED
Last Update Posted: 2018-08-27
First Post: 2007-12-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Haemophilus Influenzae Type b View
None Neisseria Meningitidis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Conjugate vaccine View
None Persistence View
None Hib vaccine View
None Combination vaccine View
None Meningococcal vaccine View
None Safety View
None Preterm/full-term infants View
None Immunogenicity View